UNC2025, a potent and orally bioavailable MER/FLT3 dual inhibitor.
摘要：
We previously reported a potent small molecule Mer tyrosine kinase inhibitor UNC1062. However, its poor PK properties prevented further assessment in vivo. We report here the sequential modification of UNC1062 to address DMPK properties and yield a new potent and highly orally bioavailable Mer inhibitor, 11, capable of inhibiting Mer phosphorylation in vivo, following oral dosing as demonstrated by pharmaco-dynamic (PD) studies examining phospho-Mer in leukemic blasts from mouse bone marrow. Kinome profiling versus more than 300 kinases in vitro and cellular selectivity assessments demonstrate that 11 has similar subnanomolar activity against Flt3, an additional important target in acute myelogenous leukemia (AML), with pharmacologically useful selectivity versus other kinases examined.
展开
DOI：
10.1021/jm500749d
被引量：
年份：
2014
国家科技图书文献中心
(权威机构)
ACS
(全网免费下载)
ACS
Semantic Scholar
(全网免费下载)
掌桥科研
查看更多
万方医学
NCBI
NCBI
Europe PMC
Europe PMC
(全网免费下载)
ResearchGate
ResearchGate
(全网免费下载)
EBSCO
Citeseer
(全网免费下载)
broker.edina.ac.uk
scienceopen.com
(全网免费下载)
evidences.carpha.bvsalud.org
学术范
(全网免费下载)
onacademic.com
pubfacts.com
s3-eu-west-1.amazonaws.com
(全网免费下载)
学术范
scienceopen.com
ACS
(全网免费下载)
Semantic Scholar
(全网免费下载)
Europe PMC
(全网免费下载)
ResearchGate
(全网免费下载)
Citeseer
(全网免费下载)
s3-eu-west-1.amazonaws.com
(全网免费下载)
scienceopen.com
(全网免费下载)
学术范
(全网免费下载)
通过文献互助平台发起求助，成功后即可免费获取论文全文。
相似文献
参考文献
引证文献
辅助模式
引用
文献可以批量引用啦~
欢迎点我试用！
